1. From the Division of Applied Medicine, University of Aberdeen, Aberdeen, United Kingdom;
2. Respiratory and Inflammation Research, AstraZeneca, Cheshire, United Kingdom; and the
3. Department of Internal Medicine II, University of Regensburg, Regensburg, Germany.